170 related articles for article (PubMed ID: 81986)
1. Double-blind withdrawal trial of azathioprine as maintenance treatment for Crohn's disease.
O'Donoghue DP; Dawson AM; Powell-Tuck J; Bown RL; Lennard-Jones JE
Lancet; 1978 Nov; 2(8097):955-7. PubMed ID: 81986
[TBL] [Abstract][Full Text] [Related]
2. A randomized, double-blind, controlled withdrawal trial in Crohn's disease patients in long-term remission on azathioprine.
Lémann M; Mary JY; Colombel JF; Duclos B; Soule JC; Lerebours E; Modigliani R; Bouhnik Y;
Gastroenterology; 2005 Jun; 128(7):1812-8. PubMed ID: 15940616
[TBL] [Abstract][Full Text] [Related]
3. Withdrawal of long-term maintenance treatment with azathioprine tends to increase relapse risk in patients with Crohn's disease.
Wenzl HH; Primas C; Novacek G; Teml A; Öfferlbauer-Ernst A; Högenauer C; Vogelsang H; Petritsch W; Reinisch W
Dig Dis Sci; 2015 May; 60(5):1414-23. PubMed ID: 25381202
[TBL] [Abstract][Full Text] [Related]
4. Randomized controlled azathioprine withdrawal after more than two years treatment in Crohn's disease: increased relapse rate the following year.
Vilien M; Dahlerup JF; Munck LK; Nørregaard P; Grønbaek K; Fallingborg J
Aliment Pharmacol Ther; 2004 Jun; 19(11):1147-52. PubMed ID: 15153167
[TBL] [Abstract][Full Text] [Related]
5. How should we treat Crohn's disease?
Sleisenger MH
N Engl J Med; 1980 May; 302(18):1024-6. PubMed ID: 6102738
[No Abstract] [Full Text] [Related]
6. A controlled trial of azathioprine in Crohn's disease.
Rosenberg JL; Levin B; Wall AJ; Kirsner JB
Am J Dig Dis; 1975 Aug; 20(8):721-6. PubMed ID: 1098449
[TBL] [Abstract][Full Text] [Related]
7. Place of azathioprine for Crohn's disease.
Brooke BN; Cave DR; King DW
Lancet; 1976 May; 1(7968):1041-2. PubMed ID: 57449
[TBL] [Abstract][Full Text] [Related]
8. Azathioprine withdrawal in patients with Crohn's disease maintained on prolonged remission: a high risk of relapse.
Treton X; Bouhnik Y; Mary JY; Colombel JF; Duclos B; Soule JC; Lerebours E; Cosnes J; Lemann M;
Clin Gastroenterol Hepatol; 2009 Jan; 7(1):80-5. PubMed ID: 18849016
[TBL] [Abstract][Full Text] [Related]
9. A controlled double blind study of azathioprine in the management of Crohn's disease.
Candy S; Wright J; Gerber M; Adams G; Gerig M; Goodman R
Gut; 1995 Nov; 37(5):674-8. PubMed ID: 8549944
[TBL] [Abstract][Full Text] [Related]
10. Controlled trial of azathioprine in Crohn's disease.
Rhodes J; Bainton D; Beck P; Campbell H
Lancet; 1971 Dec; 2(7737):1273-6. PubMed ID: 4143532
[TBL] [Abstract][Full Text] [Related]
11. Optimum duration of treatment with 6-mercaptopurine for Crohn's disease.
Kim PS; Zlatanic J; Korelitz BI; Gleim GW
Am J Gastroenterol; 1999 Nov; 94(11):3254-7. PubMed ID: 10566725
[TBL] [Abstract][Full Text] [Related]
12. Azathioprine is superior to budesonide in achieving and maintaining mucosal healing and histologic remission in steroid-dependent Crohn's disease.
Mantzaris GJ; Christidou A; Sfakianakis M; Roussos A; Koilakou S; Petraki K; Polyzou P
Inflamm Bowel Dis; 2009 Mar; 15(3):375-82. PubMed ID: 19009634
[TBL] [Abstract][Full Text] [Related]
13. Shortcomings of the National Crohn's Disease Study: the exclusion of azathioprine without adequate trial.
Korelitz BI; Present DH
Gastroenterology; 1981 Jan; 80(1):193-6. PubMed ID: 6108892
[No Abstract] [Full Text] [Related]
14. Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's disease in clinical practice.
Ampuero J; Rojas-Feria M; Castro-Fernández M; Millán-Lorenzo M; Guerrero-Jiménez P; Romero-Gómez M
J Gastroenterol Hepatol; 2016 Jan; 31(1):112-8. PubMed ID: 26173493
[TBL] [Abstract][Full Text] [Related]
15. Treatment of Crohn's disease with azathioprine: a controlled evaluation.
Klein M; Binder HJ; Mitchell M; Aaronson R; Spiro H
Gastroenterology; 1974 May; 66(5):916-22. PubMed ID: 4597093
[No Abstract] [Full Text] [Related]
16. Early azathioprine therapy is no more effective than placebo for newly diagnosed Crohn's disease.
Panés J; López-Sanromán A; Bermejo F; García-Sánchez V; Esteve M; Torres Y; Domènech E; Piqueras M; Gomez-García M; Gutiérrez A; Taxonera C; Sans M;
Gastroenterology; 2013 Oct; 145(4):766-74.e1. PubMed ID: 23770132
[TBL] [Abstract][Full Text] [Related]
17. Controlled trial of azathioprine in Crohn's disease.
Willoughby JM; Beckett J; Kumar PJ; Dawson AM
Lancet; 1971 Oct; 2(7731):944-7. PubMed ID: 4107900
[No Abstract] [Full Text] [Related]
18. Azathioprine in the treatment of Crohn's disease.
Rhodes J
Br J Surg; 1972 Oct; 59(10):819-21. PubMed ID: 4562174
[No Abstract] [Full Text] [Related]
19. A multicenter, randomized, double-blind trial of everolimus versus azathioprine and placebo to maintain steroid-induced remission in patients with moderate-to-severe active Crohn's disease.
Reinisch W; Panés J; Lémann M; Schreiber S; Feagan B; Schmidt S; Sturniolo GC; Mikhailova T; Alexeeva O; Sanna L; Haas T; Korom S; Mayer H
Am J Gastroenterol; 2008 Sep; 103(9):2284-92. PubMed ID: 18671816
[TBL] [Abstract][Full Text] [Related]
20. A double-blind trial of azathioprine in Crohn's disease.
Willoughby JM; Kumar P; Beckett J; Dawson AM
Gut; 1971 Oct; 12(10):864. PubMed ID: 4941688
[No Abstract] [Full Text] [Related]
[Next] [New Search]
